Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease invasive aspergillosis
Phenotype C0376545|hematological malignancies
Sentences 8
PubMedID- 21417869 invasive aspergillosis in children with hematological malignancies.
PubMedID- 21108574 This study aimed at comparing a real-time pcr assay and a pcr-elisa assay of both serum and bronchoalveolar lavage (bal) samples for the diagnosis of invasive aspergillosis (ia) in patients with hematological malignancies.
PubMedID- 20367932 [combination of real-time polymerase chain reaction assay and serum galactomannan in the diagnosis of invasive aspergillosis in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation].
PubMedID- 23084969 Objectives: to evaluate risk factors, diagnostic procedures, and treatment outcomes of invasive aspergillosis (ia) in patients with hematological malignancies.
PubMedID- 21905944 Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
PubMedID- 23620764 invasive aspergillosis in patients with non-hematological malignancies is characterized by high mortality (60–100%) [6], [10], [11], which probably reflects the limitations of current diagnostic tools based on radiology or microbiology and the low index of clinical suspicion.
PubMedID- 25473570 invasive aspergillosis can be associated with hematological malignancies.
PubMedID- 24740084 This study was undertaken to examine the performance of the fungitell beta-glucan (bg) assay, to compare it with that of the galactomannan (gm) test for the diagnosis of invasive aspergillosis (ia) in patients with hematological malignancies, and to examine the rates of false-positive bg and gm test results due to beta-lactam antibiotics among sera of patients with gram-positive or gram-negative bacteremia and selected sera with false-positive results from the gm test.

Page: 1